Liu Wei Quan - Net Worth and Insider Trading
Liu Wei Quan Net Worth
The estimated net worth of Liu Wei Quan is at least $5 Million dollars as of 2024-06-22. Liu Wei Quan is the Director of Jiangzhong Pharmaceutical Co Ltd and owns about 219,000 shares of Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) stock worth over $5 Million. Details can be seen in Liu Wei Quan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Liu Wei Quan has not made any transactions after 2021-11-30 and currently still holds the listed stock(s).
Transaction Summary of Liu Wei Quan
Liu Wei Quan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Liu Wei Quan owns 1 companies in total, including Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) .
Click here to see the complete history of Liu Wei Quan’s form 4 insider trades.
Insider Ownership Summary of Liu Wei Quan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600750 | Jiangzhong Pharmaceutical Co Ltd | 2021-11-30 | Director |
Liu Wei Quan Latest Holdings Summary
Liu Wei Quan currently owns a total of 1 stock. Liu Wei Quan owns 219,000 shares of Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) as of November 30, 2021, with a value of $5 Million.
Latest Holdings of Liu Wei Quan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600750 | Jiangzhong Pharmaceutical Co Ltd | 2021-11-30 | 219,000 | 23.95 | 5,245,050 |
Holding Weightings of Liu Wei Quan
Liu Wei Quan Form 4 Trading Tracker
According to the SEC Form 4 filings, Liu Wei Quan has made a total of 1 transactions in Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Jiangzhong Pharmaceutical Co Ltd is the sale of 219,000 shares on November 30, 2021, which brought Liu Wei Quan around $1 Million.
Insider Trading History of Liu Wei Quan
- 1
Liu Wei Quan Trading Performance
GuruFocus tracks the stock performance after each of Liu Wei Quan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Liu Wei Quan is 1.94%. GuruFocus also compares Liu Wei Quan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Liu Wei Quan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Liu Wei Quan's insider trading performs compared to the benchmark.
Performance of Liu Wei Quan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.52 | | | | | |
| Relative Return to S&P 500(%) | 5.88 | | | | | |
Liu Wei Quan Ownership Network
Liu Wei Quan Owned Company Details
What does Jiangzhong Pharmaceutical Co Ltd do?
Who are the key executives at Jiangzhong Pharmaceutical Co Ltd?
Liu Wei Quan is the Director of Jiangzhong Pharmaceutical Co Ltd.
Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangzhong Pharmaceutical Co Ltd (SHSE:600750) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jiangzhong Pharmaceutical Co Ltd (SHSE:600750)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jiangzhong Pharmaceutical Co Ltd Insider Transactions
Liu Wei Quan Mailing Address
Above is the net worth, insider trading, and ownership report for Liu Wei Quan. Currently GuruFocus does not have mailing address information for Liu Wei Quan.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
